CHDI SELECTS EVOTEC AS STRATEGIC DRUG DISCOVERY PARTNER IN THE SEARCH FOR HUNTINGTON DISEASE TREATMENTS

Evotec AG announced that CHDI, Inc., a not-for profit organisation pursuing a biotech approach to finding therapies for Huntington Disease, has chosen Evotec as a strategic partner for helping them advance its drug discovery programmes. Pipeline Review (http://www.pipelinereview.com/joomla/content/view/5804/117/)